Please assess the completion status of the following clinical trial:

Trial Title: Hypofractionated Radiotherapy for Nonmelanoma Skin Cancer

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Cosmesis not important~* Basal cell carcinoma (BCC) or squamous cell carcinoma (SCC) of any differentiation~* Clinical stage I and II~* Location on the thorax, abdomen, pelvis (except perineum), arm, thigh, cheek~* Patient with up to 3 injuries eligible for the study~* Karnofsky Performance Status (KPS) ≥ 70%~* Age \> 18 years~* Informed Consent signed by the patient consenting to undergo the study~Exclusion Criteria:~* Indian Race~* Prior treatment for their skin cancer~* More than three synchronous lesions to treatment with RT~* Basal syndrome, xeroderma, vitiligo and albinism~* Immunosuppression~* Prior burn at the tumor site~* Tumor \> 5 cm~* Age \<18 years~* Carrier mental incapacity~* People in a relationship of dependence as prisoners, soldiers, students, staff, etc..

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 30 Gy in 5 fractions of 6 Gy (Type: EXPERIMENTAL): tumors ≤ 2 cm in diameter: 5 fractions of 600 cGy, once a day, five times a week - TDF: 89
- 40 Gy in 10 fractions of 4 Gy (Type: EXPERIMENTAL): tumors \> 2-5 cm in diameter: 10 fractions of 400 cGy, once a day, five times a week - TDF: 96

Based on this trial design, predict the completion outcome and termination type (if applicable).